Diffuse exanthematous drug eruption associated with intravenous immunoglobulin.

Authors

Anish Paudel, Tower Health - Reading Hospital
Sijan Basnet, Tower Health - Reading Hospital
Biswaraj Tharu
Nidrit Bohra, Tower Health - Reading Hospital

Document Type

Article

Publication Date

8-19-2020

Abstract

Diffuse exanthematous drug eruption due to intravenous immunoglobulin (IVIg) is a rare adverse event reported only in case reports. We present a case of a 71-year-old woman with a diffuse maculopapular rash 5 days after receiving an IVIg infusion for treatment of chronic inflammatory demyelinating polyneuropathy. She was managed conservatively with antihistamines; she was already receiving prednisone 25 mg daily as part of treatment for the neuropathy. The rash resolved over 2 weeks.

Publication Title

Proc (Bayl Univ Med Cent)

Volume

34

Issue

1

First Page

81

Last Page

82

Recommended Citation

Paudel, A., Basnet, S., Tharu, B., & Bohra, N. (2020). Diffuse exanthematous drug eruption associated with intravenous immunoglobulin.. Proc (Bayl Univ Med Cent), 34 (1), 81-82. Retrieved from https://scholarcommons.towerhealth.org/gme_int_med_resident_program_read/576